meta|Evidence - COVID-19
Member of the meta|Evidence galaxy
Treament | Trials | auto | |||||
---|---|---|---|---|---|---|---|
immune thrombocytopenia | thrombocytopenia | VTE with thrombocytopenia | ATE with thrombocytopenia | stroke with thrombocytopenia | |||
|
9 | OBS 1.20 [0.70; 2.04], 2 studies, I2=0% inconclusive result | - | OBS 0.86 [0.58; 1.27], 1 study, I2=0% inconclusive result | - | - | |
|
39 | OBS 1.20 [0.70; 2.04], 2 studies, I2=0% inconclusive result | OBS 0.94 [0.66; 1.33], 1 study, I2=0% inconclusive result | OBS 0.86 [0.58; 1.27], 1 study, I2=0% inconclusive result | - | - | |
|
19 | OBS 1.49 [0.84; 2.63], 3 studies, I2=75% inconclusive result | OBS 1.32 [1.04; 1.68], 3 studies, I2=92% statistically significant harm | OBS 1.09 [0.52; 2.29], 1 study, I2=0% inconclusive result | OBS 1.57 [0.65; 3.79], 1 study, I2=0% inconclusive result | OBS 2.21 [0.99; 4.92], 1 study, I2=0% inconclusive result | |
|
9 | - | - | - | - | - |
Statistically conclusive: statistically significant with a strict control of overall risk of type 1 error (statistically demonstrated), does not take into account the risk of bias; suggested: nominally statistically significant but without a strict control of overall risk of type 1 error; inconclusive: not nominally statistically significant
149
treatments |
718
studies with results |
1743
studies screend |
1629
references |
This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N), Université de Lyon (UdL/Idex), and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.
- About - Our approach - Credits - RSS Made with in Lyon - Contact us - Privacy policy -